The antimalarial drug amodiaquine possesses anti-ZIKA virus activities

Sofosbuvir: an antiviral drug with potential efficacy against Zika infection

(2017) Sandra E. Reznik et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Development of a high-throughput colorimetric Zika virus infection assay

(2017) Janis A. Müller et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Zika Virus Infection

(2017) Debbie-Ann T. Shirley et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus

(2017) Keiko Rausch et al.   Cell Reports

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication

(2017) Carolina Q. Sacramento et al.   Scientific Reports

Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis

(2017) Sergey A. Shiryaev et al.   Scientific Reports

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection

(2016) Nicholas J. Barrows et al.   Cell Host & Microbe

Novel strategies for discovering inhibitors of Dengue and Zika fever

(2016) Huda Makhluf et al.   Expert Opinion on Drug Discovery

Identification of resveratrol analogs as potent anti-dengue agents using a cell-based assay

(2016) Ying-Shan Han et al.   JOURNAL OF MEDICAL VIROLOGY

Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials

(2016) Abdo A. Elfiky   JOURNAL OF MEDICAL VIROLOGY

Zika Virus: A Serious Global Health Threat

(2016) Candice J. McNeil et al.   JOURNAL OF TROPICAL PEDIATRICS

A sensitive virus yield assay for evaluation of Antivirals against Zika Virus

(2016) Scott Goebel et al.   JOURNAL OF VIROLOGICAL METHODS

The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity

(2016) Abdul Naeem et al.   MOLECULES

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

(2016) Miao Xu et al.   NATURE MEDICINE

Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models

(2016) Rodrigo Delvecchio et al.   Viruses-Basel

The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model

(2016) Joanna Zmurko et al.   PLoS Neglected Tropical Diseases

Zika Virus: Medical Countermeasure Development Challenges

(2016) Robert W. Malone et al.   PLoS Neglected Tropical Diseases

Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus

(2016) Yong-Qiang Deng et al.   Open Forum Infectious Diseases

Reemergence of chloroquine (CQ) analogs as multi-targeting antimalarial agents: A review

(2015) Md. Mushtaque et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

A resveratrol analog termed 3,3′,4,4′,5,5′-hexahydroxy-trans-stilbene is a potent HIV-1 inhibitor

(2015) Ying-Shan Han et al.   JOURNAL OF MEDICAL VIROLOGY

Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting

(2015) Leeor Zilbermintz et al.   Scientific Reports

Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity

(2014) Siwaporn Boonyasuppayakorn et al.   ANTIVIRAL RESEARCH

Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus

(2014) Hussin A Rothan et al.   BMC MICROBIOLOGY

A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents

(2013) Peter B. Madrid et al.   PLoS One

Quantitative real-time PCR detection of Zika virus and evaluation with field-caught Mosquitoes

(2013) Oumar Faye et al.   Virology Journal

Characterizing the Anti-HIV Activity of Papuamide A

(2008) Cynthia Andjelic et al.   Marine Drugs